Vimarsana
Biggest News Aggregation in the World

Page 5 - Mind Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mind Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mind Capital Today - Breaking & Trending Today

Sorenson Impact University Venture Fund Joins Leading Investors to Close $10M Financing Round for Global Leader in Brain-Computer Interface Technology - Vimarsana News

Sorenson Impact University Venture Fund Joins Leading Investors to Close $10M Financing Round for Global Leader in Brain-Computer Interface Technology

University Venture Fund II has joined lead investor Christian Angermayer’s re.Mind Capital, an SPV sponsored by Peter Thiel, German entrepreneur Tim Sievers,

Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs - Vimarsana News

Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs

Neumora Therapeutics unveiled $500 million in capital and a research partnership with Amgen. The startup analyzes neurological data to inform its drug research and development; President and Chief Operating Officer Lori Lyons-Williams said researching psychiatric drugs and neurodegenerative drugs within the same company allows brain insights from one area to inform the other.

Synchron Raises $40M in Series B Funding - Vimarsana News

Synchron Raises $40M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Synchron Secures $40M in Series B led by Khosla Ventures to Launch U.S. Clinical Trials of Minimally Invasive Brain Computer Interface - Vimarsana News

Synchron Secures $40M in Series B led by Khosla Ventures to Launch U.S. Clinical Trials of Minimally Invasive Brain Computer Interface

Synchron’s flagship StentrodeTM endovascular implant does not require open brain surgery and has obtained FDA Breakthrough Device Designation for the treatment of paralysisThe New York based company is already conducting human trials in Australia and is expected to commence a U.S. clinical trial in 2021NEW YORK--(BUSINESS WIRE)--Synchron, a brain interface platform company,

Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology - Vimarsana News

Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

Share this article Share this article SALT LAKE CITY, May 19, 2021 /PRNewswire/ -- Blackrock Neurotech, the world's leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer's re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact's University Venture Fund II. Christian Angermayer and Jan Hardorp of re.Mind, as well as Tim Sievers will join the Blackrock Neurotech Board of Directors. The funding will be used to further expand the number of programs ...